228 related articles for article (PubMed ID: 31285889)
41. Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma.
Vigneswaran WT; Kircheva DY; Ananthanarayanan V; Watson S; Arif Q; Celauro AD; Kindler HL; Husain AN
Ann Thorac Surg; 2017 Mar; 103(3):962-966. PubMed ID: 27765170
[TBL] [Abstract][Full Text] [Related]
42. Surgical treatment of pleural recurrence of thymoma: is hyperthermic intrathoracic chemotherapy worthwhile?
Aprile V; Bacchin D; Korasidis S; Nesti A; Marrama E; Ricciardi R; Petrini I; Ambrogi MC; Paladini P; Lucchi M
Interact Cardiovasc Thorac Surg; 2020 May; 30(5):765-772. PubMed ID: 32170942
[TBL] [Abstract][Full Text] [Related]
43. Intraoperative intracavitary hyperthermic chemotherapy for malignant pleural mesothelioma.
Okabe K
Ann Transl Med; 2017 Jun; 5(11):233. PubMed ID: 28706901
[TBL] [Abstract][Full Text] [Related]
44. Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly.
Williams T; Duraid H; Watson S; Durkin A; Todd K; Kindler HL; Vigneswaran WT
Ann Thorac Surg; 2015 Nov; 100(5):1868-74. PubMed ID: 26319490
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma.
van Ruth S; van Tellingen O; Korse CM; Verwaal VJ; Zoetmulder FA
Anticancer Drugs; 2003 Jan; 14(1):57-65. PubMed ID: 12544259
[TBL] [Abstract][Full Text] [Related]
46. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.
Rosenzweig KE; Zauderer MG; Laser B; Krug LM; Yorke E; Sima CS; Rimner A; Flores R; Rusch V
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1278-83. PubMed ID: 22607910
[TBL] [Abstract][Full Text] [Related]
47. The management of the diaphragm during radical surgery for malignant pleural mesothelioma.
Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
Eur J Cardiothorac Surg; 2016 Aug; 50(2):311-6. PubMed ID: 27005974
[TBL] [Abstract][Full Text] [Related]
48. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.
Infante M; Morenghi E; Bottoni E; Zucali P; Rahal D; Morlacchi A; Ascolese AM; De Rose F; Navarria P; Crepaldi A; Testori A; Voulaz E; Errico V; Perrino M; Scorsetti M; Chiti A; Santoro A; Alloisio M
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1077-1082. PubMed ID: 27330149
[TBL] [Abstract][Full Text] [Related]
49. Clinical indications and results after chest wall resection for recurrent mesothelioma.
Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
[TBL] [Abstract][Full Text] [Related]
50. Salvage debulking surgery and hyperthermic intrathoracic chemotherapy for massive recurrent mesothelioma in the mediastinum.
Poon SS; Alberti C; Nardini M; Migliore M
Interact Cardiovasc Thorac Surg; 2022 Jun; 35(1):. PubMed ID: 35218349
[TBL] [Abstract][Full Text] [Related]
51. Is Hyperthermic Intrathoracic Chemotherapy (HITHOC) Safe and Efficacious in Masaoka-Koga Stage-IVA Thymoma? A Pilot Study.
Kumar A; Pulle MV; Asaf BB; Puri HV; Kumar A; Bishnoi S
Indian J Surg Oncol; 2021 Dec; 12(4):830-837. PubMed ID: 35110910
[TBL] [Abstract][Full Text] [Related]
52. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
[TBL] [Abstract][Full Text] [Related]
53. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study.
Ratto GB; Civalleri D; Esposito M; Spessa E; Alloisio A; De Cian F; Vannozzi MO
J Thorac Cardiovasc Surg; 1999 Apr; 117(4):759-65. PubMed ID: 10096972
[TBL] [Abstract][Full Text] [Related]
54. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
[TBL] [Abstract][Full Text] [Related]
55. Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.
Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):696-702. PubMed ID: 29049744
[TBL] [Abstract][Full Text] [Related]
56. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
Burt BM; Cameron RB; Mollberg NM; Kosinski AS; Schipper PH; Shrager JB; Vigneswaran WT
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):30-5. PubMed ID: 24726744
[TBL] [Abstract][Full Text] [Related]
57. Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients with Intrapleural Dissemination of Peritoneal Surface Malignancies.
Nikiforchin A; Gushchin V; King MC; Baron E; Lopez-Ramirez F; Sardi A
Ann Surg Oncol; 2021 Dec; 28(13):9126-9135. PubMed ID: 34263367
[TBL] [Abstract][Full Text] [Related]
58. Subtotal Pleurectomy with Intrathoracic Chemo Hyperthermia (HITHOC) for IVa Thymomas: De Novo Versus Recurrent Pleural Disease.
Chappuy B; Drevet G; Clermidy H; Rosamel P; Duruisseaux M; Couraud S; Grima R; Soldea V; Chalabreysse L; Tronc F; Girard N; Maury JM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291819
[TBL] [Abstract][Full Text] [Related]
59. Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study.
Marulli G; Breda C; Fontana P; Ratto GB; Leoncini G; Alloisio M; Infante M; Luzzi L; Paladini P; Oliaro A; Ruffini E; Benvenuti MR; Pariscenti G; Spaggiari L; Casiraghi M; Rusca M; Carbognani P; Ampollini L; Facciolo F; Leuzzi G; Mucilli F; Camplese P; Romanello P; Perissinotto E; Rea F
Eur J Cardiothorac Surg; 2017 Jul; 52(1):63-69. PubMed ID: 28419212
[TBL] [Abstract][Full Text] [Related]
60. The importance of surgical staging in the treatment of malignant pleural mesothelioma.
Rusch VW; Venkatraman E
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):815-25; discussion 825-6. PubMed ID: 8614142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]